ArticleAnnals of thoracic surgery short reports2026
Is Reconstructing the Right Ventricle-Pulmonary Artery Continuity Without a Conduit Worthwhile? Reevaluation in the Modern Era.
Article in Annals of thoracic surgery short reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Damus-Ratelli Procedure for Double Outlet Right Ventricle With Doubly-Committed Subarterial Ventricular Septal Defect.Annals of thoracic surgery short reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This retrospective study assessed the feasibility of our right ventricle-pulmonary artery reconstruction technique without a conduit. Methods: This technique consists of a connection of the pulmonary artery to the right ventricular incision for the posterior wall of the new route established exclusively using autologous tissue, and a transannular patch using a glutaraldehyde-treated autologous pericardium as the anterior wall incorporating a monocusp as pulmonary valve substitute using an extended polytetrafluoroethylene membrane. Results: From November 2007 to June 2024, 21 consecutive patients (median age, 15.2 months; median body weight, 8.7 kg) underwent this technique after 32 preparatory palliations in 20 patients. The diameter of the new route was less than 12 mm in 76% of patients. The left atrial appendage was interposed in the posterior wall in 15 patients (71.4%). There was 1 death due to fulminant pneumonia during the follow-up period (median, 5 years; maximum, 16.5 years). Eight patients required catheter balloon dilation after a median of 1.4 years postoperatively, with estimated free rates of initial catheter intervention of 57.4% and 38.2% after 5 and 10 years, respectively. Catheter intervention failed in 2 patients with immobile restrictive monocusps that were replaced with a new cusp after 2.5 years or a bioprosthetic valve after 15.6 years postoperatively. The estimated 5-year free reoperation rate was 92.9%. Conclusions: This technique could provide a reasonable alternative to the use of a small-diameter conduit, even in the modern era.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.